A wet AMD biosimilar approval leads this week’s recap, plus Medicare pay updates and tips to avoid burnout and losing patients.
|Videos|February 27, 2021
Dr. Ben Casella muses on COVID-19 and vaccine
Join the conversation
Advertisement
Ben Casella, OD, FAAO, chief optometric editor of Optometry Times®, talks with Gretchyn Bailey, NCLC, FAAO, editor in chief and content channel director, about the state of the pandemic and vaccine distribution. Join the conversation!
Advertisement
Related to this article
ODs face a $32.63 Medicare conversion factor in 2027, plus 80% payment for the lower-cost service when an E/M visit and 0-day procedure share a date.
Christopher Browning, OD, and Nicholas Garn, OD, now offer cataract surgery and refractive lens exchange in their own practices.
According to Raphael Rostenne, CTO of EyeCarePro, "anything that takes time" has the potential to frustrate patients, especially before they're in a practitioner's chair.
Kansas, Tennessee, and Vermont expanded optometric scope in 2026, while vision plan reform and a proposed Medicare fee schedule cut affect practice management.
This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host Diana Canto-Sims, OD.
This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Indiana optometrists open state’s first OD-owned surgical suites
2
2027 Medicare fee schedule trims same-day E/M, 0-day procedure pay
3
Takeaways from this week in optometry: November 2-6
4
FDA approves ranibizumab biosimilar Lucamzi for wet AMD
5